Peter Iversen

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher, Ali Amin Al Olama, Sonja I. Berndt et al. · Nature Genetics · 2018 · 1K citations · Full text

Life Sciences, Genetics, Oncology +14

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · European Urology · 2016 · 419 citations · Full text

Medicine, Oncology, Pharmacology +13

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

Peter Iversen, C. Tyrrell, Amir V. Kaisary et al. · The Journal of Urology · 2000 · 345 citations

Medicine, Oncology, Urology +10

A Randomised Comparison of ‘Casodex’<sup>TM</sup> (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer

CJ Tyrrell, Amir Kaisary, Peter Iversen et al. · European Urology · 1998 · 309 citations

Medicine, Oncology, Pharmacotherapy +16